ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 61 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $343,000 | -33.1% | 131,912 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $513,000 | +44.1% | 131,912 | -0.2% | 0.00% | – |
| Q2 2016 | $356,000 | +1994.1% | 132,237 | +2239.6% | 0.00% | – |
| Q1 2016 | $17,000 | -26.1% | 5,652 | -3.7% | 0.00% | – |
| Q4 2015 | $23,000 | +35.3% | 5,867 | +3.3% | 0.00% | – |
| Q3 2015 | $17,000 | -29.2% | 5,681 | 0.0% | 0.00% | – |
| Q2 2015 | $24,000 | -91.5% | 5,681 | -92.3% | 0.00% | – |
| Q1 2015 | $283,000 | -42.2% | 73,324 | +0.6% | 0.00% | -100.0% |
| Q4 2014 | $490,000 | +21.3% | 72,861 | -1.0% | 0.00% | 0.0% |
| Q3 2014 | $404,000 | -45.1% | 73,614 | +2.6% | 0.00% | 0.0% |
| Q2 2014 | $736,000 | -4.7% | 71,758 | +11.6% | 0.00% | 0.0% |
| Q1 2014 | $772,000 | +5.9% | 64,316 | -0.2% | 0.00% | 0.0% |
| Q4 2013 | $729,000 | +3.6% | 64,436 | -1.4% | 0.00% | 0.0% |
| Q3 2013 | $704,000 | +39.4% | 65,352 | +19.9% | 0.00% | 0.0% |
| Q2 2013 | $505,000 | – | 54,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |